These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 18581327

  • 1. Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells.
    Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, Drexhage HA, Versnel MA.
    Eur J Immunol; 2008 Jul; 38(7):2024-33. PubMed ID: 18581327
    [Abstract] [Full Text] [Related]

  • 2. Increased frequency of CD16+ monocytes and the presence of activated dendritic cells in salivary glands in primary Sjögren syndrome.
    Wildenberg ME, Welzen-Coppens JM, van Helden-Meeuwsen CG, Bootsma H, Vissink A, van Rooijen N, van de Merwe JP, Drexhage HA, Versnel MA.
    Ann Rheum Dis; 2009 Mar; 68(3):420-6. PubMed ID: 18397959
    [Abstract] [Full Text] [Related]

  • 3. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.
    Båve U, Nordmark G, Lövgren T, Rönnelid J, Cajander S, Eloranta ML, Alm GV, Rönnblom L.
    Arthritis Rheum; 2005 Apr; 52(4):1185-95. PubMed ID: 15818675
    [Abstract] [Full Text] [Related]

  • 4. Activation of the type I interferon pathway in primary Sjögren's syndrome: an update.
    Vakaloglou KM, Mavragani CP.
    Curr Opin Rheumatol; 2011 Sep; 23(5):459-64. PubMed ID: 21760509
    [Abstract] [Full Text] [Related]

  • 5. Type I interferons in Sjögren's syndrome.
    Yao Y, Liu Z, Jallal B, Shen N, Rönnblom L.
    Autoimmun Rev; 2013 Mar; 12(5):558-66. PubMed ID: 23201923
    [Abstract] [Full Text] [Related]

  • 6. The possible etiopathogenic genes of Sjögren's syndrome.
    Takei M, Shiraiwa H, Azuma T, Hayashi Y, Seki N, Sawada S.
    Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
    Nordmark G, Alm GV, Rönnblom L.
    Nat Clin Pract Rheumatol; 2006 May; 2(5):262-9. PubMed ID: 16932699
    [Abstract] [Full Text] [Related]

  • 8. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP, Sagalovskiy I, Guo Q, Nezos A, Kapsogeorgou EK, Lu P, Liang Zhou J, Kirou KA, Seshan SV, Moutsopoulos HM, Crow MK.
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [Abstract] [Full Text] [Related]

  • 9. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
    Maria NI, Steenwijk EC, IJpma AS, van Helden-Meeuwsen CG, Vogelsang P, Beumer W, Brkic Z, van Daele PL, van Hagen PM, van der Spek PJ, Drexhage HA, Versnel MA.
    Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
    [Abstract] [Full Text] [Related]

  • 10. Association between IFN-alpha and primary Sjogren's syndrome.
    Zheng L, Zhang Z, Yu C, Tu L, Zhong L, Yang C.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):e12-8. PubMed ID: 19101478
    [Abstract] [Full Text] [Related]

  • 11. Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome.
    Vogelsang P, Brun JG, Oijordsbakken G, Skarstein K, Jonsson R, Appel S.
    Ann Rheum Dis; 2010 Jun; 69(6):1235-8. PubMed ID: 19914903
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
    Brkic Z, Maria NI, van Helden-Meeuwsen CG, van de Merwe JP, van Daele PL, Dalm VA, Wildenberg ME, Beumer W, Drexhage HA, Versnel MA.
    Ann Rheum Dis; 2013 May; 72(5):728-35. PubMed ID: 22736090
    [Abstract] [Full Text] [Related]

  • 13. Expression of the interferon-gamma-inducible 10-kd protein and CXC receptor 3 in the salivary gland lesions of patients with Sjögren's syndrome: comment on the article by Ogawa et al.
    Sfriso P, Calabrese F, Grava C, Agostini C, Punzi L, Oliviero F, Botsios C, Ostuni PA, Todesco S.
    Arthritis Rheum; 2003 Aug; 48(8):2390-1; author reply 2391-2. PubMed ID: 12905497
    [No Abstract] [Full Text] [Related]

  • 14. Type I IFN signature in primary Sjögren's syndrome patients.
    Brkic Z, Versnel MA.
    Expert Rev Clin Immunol; 2014 Apr; 10(4):457-67. PubMed ID: 24450331
    [Abstract] [Full Text] [Related]

  • 15. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
    Cha S, Brayer J, Gao J, Brown V, Killedar S, Yasunari U, Peck AB.
    Scand J Immunol; 2004 Dec; 60(6):552-65. PubMed ID: 15584966
    [Abstract] [Full Text] [Related]

  • 16. Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjögren's syndrome antigens and nuclear ribonucleoprotein antigens.
    Wuttge DM, Lood C, Tufvesson E, Scheja A, Truedsson L, Bengtsson AA, Hesselstrand R.
    Scand J Rheumatol; 2013 Dec; 42(3):235-40. PubMed ID: 23379597
    [Abstract] [Full Text] [Related]

  • 17. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
    Lövgren T, Eloranta ML, Kastner B, Wahren-Herlenius M, Alm GV, Rönnblom L.
    Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
    [Abstract] [Full Text] [Related]

  • 18. Primary Sjögren's syndrome and the type I interferon system.
    Nordmark G, Eloranta ML, Ronnblom L.
    Curr Pharm Biotechnol; 2012 Aug; 13(10):2054-62. PubMed ID: 22208657
    [Abstract] [Full Text] [Related]

  • 19. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.
    Maria NI, Brkic Z, Waris M, van Helden-Meeuwsen CG, Heezen K, van de Merwe JP, van Daele PL, Dalm VA, Drexhage HA, Versnel MA.
    Ann Rheum Dis; 2014 Jun; 73(6):1052-9. PubMed ID: 23831963
    [Abstract] [Full Text] [Related]

  • 20. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
    Hillen MR, Pandit A, Blokland SLM, Hartgring SAY, Bekker CPJ, van der Heijden EHM, Servaas NH, Rossato M, Kruize AA, van Roon JAG, Radstake TRDJ.
    Front Immunol; 2019 Jun; 10():2096. PubMed ID: 31552042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.